These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 6046806)

  • 1. The action of heparin as an anticoagulant.
    Shanberge JN
    Wis Med J; 1967 Jul; 66(7):278-80. PubMed ID: 6046806
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparative study of the anticoagulant action of lung and gut heparin: part 1.
    Fukuda T; Tatsumi Y; Kimura Y; Maeda H; Okuda K
    Osaka City Med J; 1980; 26(1):19-37. PubMed ID: 7267090
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma.
    Bhargava AS; Heinick J; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(6):993-6. PubMed ID: 7191280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new potent heparin. 3rd Communication: Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human blood.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(8):1256-8. PubMed ID: 7192139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Apr; 51(2):266-8. PubMed ID: 6740558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mepyramine on the histaminase release induced by heparin injection and anaphylaxis in guinea pigs.
    Sainath BR; Dave KC; Sachdev KS
    Indian J Physiol Pharmacol; 1980; 24(4):351-6. PubMed ID: 6783520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heparin treatment in cases of severe toxemia.
    Iinuma H; Fukuda T
    Biol Res Pregnancy Perinatol; 1983; 4(4):158-62. PubMed ID: 6652169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro.
    Bose P; Black S; Kadyrov M; Bartz C; Shlebak A; Regan L; Huppertz B
    Am J Obstet Gynecol; 2004 Dec; 191(6):2125-31. PubMed ID: 15592302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-anticoagulant heparin increases endothelial nitric oxide synthase activity: role of inhibitory guanine nucleotide proteins.
    Kouretas PC; Hannan RL; Kapur NK; Hendrickson R; Redmond EM; Myers AK; Kim YD; Cahill PA; Sitzmann JV
    J Mol Cell Cardiol; 1998 Dec; 30(12):2669-82. PubMed ID: 9990538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard and method independent units for heparin anticoagulant activities.
    Hemker HC; Béguin S
    Thromb Haemost; 1993 Nov; 70(5):724-8. PubMed ID: 8128425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the interrelations of ethmozine, cordarone and phenycaberan with heparin].
    Tolstopiatov BI
    Farmakol Toksikol; 1981; 44(5):586-9. PubMed ID: 7030776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro: heparin is the best anticoagulant for cardiopulmonary bypass.
    Rinder CS
    J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):816-8. PubMed ID: 8910166
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of a new potent heparin. 6th communication: The comparison of the anticoagulant effect of the sodium and calcium salts of a new potent heparin after s.c. injection in beagle dogs.
    Bhargava AS; Schöbel C; Günzel P
    Arzneimittelforschung; 1981; 31(1):79-82. PubMed ID: 7194097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heparin--new perspectives on its antiinflammatory action].
    Krasnowska M; Kwaśniewski A
    Postepy Hig Med Dosw; 1995; 49(5):661-9. PubMed ID: 8677228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The in-vitro heparin tolerance test in practice. II. The control of anticoagulant therapy].
    DALLA VOLTA S; FUSARO A
    Prog Med (Napoli); 1961 Apr; 17():223-30. PubMed ID: 13719441
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis.
    van Wyk V; Badenhorst PN; Kotzé HF
    Clin Nephrol; 1997 Dec; 48(6):381-7. PubMed ID: 9438098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.